This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

AUL Files Two Briefs Supporting The First Amendment Conscience Rights Of Hobby Lobby And Autocam Corporation

WASHINGTON, Feb. 19, 2013 /PRNewswire/ -- Americans United for Life filed two more amicus curiae briefs supporting legal challenges to the Obama Administration's unconstitutional "HHS mandate."  AUL President and CEO Dr. Charmaine Yoest noted that Obamacare continues to be "the largest expansion of abortion since Roe v. Wade compounded by violations of Americans' First Amendment Rights of Conscience. The HHS mandate forces companies and organizations to provide employees with insurance coverage for life-ending drugs and devices against their beliefs and consciences."

Dr. Yoest noted:  "In these two briefs, we continue the fight to preserve the freedom of conscience in the United States.  It is a complete affront to the Constitution to force private companies to choose between their conscientious beliefs and maintaining and growing their businesses.  This is truly the battle of our time to protect the liberties guaranteed to us over 200 years ago."

AUL filed the briefs in Hobby Lobby Stores, Inc. v. Sebelius, pending before the Tenth Circuit Court of Appeals, and Autocam Corporation v. Sebelius, pending before the Sixth Circuit Court of Appeals.  In both cases, federal district courts have refused to grant the plaintiffs relief from the draconian HHS mandate, meaning that the companies will face ruinous fines and penalties if they do not provide coverage of so-called "emergency contraception."

The briefs, available here and here, demonstrate that "emergency contraception," life-ending drugs mislabeled as "contraception," can prevent an embryo from implanting or kill an already-implanted embryo, and that forcing employers to provide coverage for such drugs violates the fundamental freedom of conscience.

The briefs were filed on behalf of the Association of American Physicians and Surgeons, American Association of Pro-Life Obstetricians & Gynecologists, Christian Medical Association, Catholic Medical Association, National Catholic Bioethics Center, Physicians for Life, and the National Association of Pro Life Nurses.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,135.72 +38.82 0.21%
S&P 500 2,101.04 +2.51 0.12%
NASDAQ 4,982.8090 +15.6680 0.32%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs